These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15863002)

  • 21. Comparative QSAR study on para-substituted aromatic sulphonamides as CAII inhibitors: information versus topological (distance-based and connectivity) indices.
    Singh J; Shaik B; Singh S; Agrawal VK; Khadikar PV; Deeb O; Supuran CT
    Chem Biol Drug Des; 2008 Mar; 71(3):244-59. PubMed ID: 18221308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated approach using protein and ligand information to analyze selectivity- and affinity-determining features of carbonic anhydrase isozymes.
    Hillebrecht A; Supuran CT; Klebe G
    ChemMedChem; 2006 Aug; 1(8):839-53. PubMed ID: 16902938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
    Huang H; Pan X; Tan N; Zeng G; Ji C
    Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric modulation of 5-HT3 serotonin receptors.
    Maksay G; Bíró T; Bugovics G
    Eur J Pharmacol; 2005 May; 514(1):17-24. PubMed ID: 15878320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.
    Agrawal VK; Singh J; Khadikar PV; Supuran CT
    Bioorg Med Chem Lett; 2006 Apr; 16(7):2044-51. PubMed ID: 16458003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrophobicity in the design of P2/P2' tetrahydropyrimidinone HIV protease inhibitors.
    Garg R; Patel D
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3767-70. PubMed ID: 15993582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
    Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
    Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands.
    Söderholm AA; Lehtovuori PT; Nyrönen TH
    J Med Chem; 2006 Jul; 49(14):4261-8. PubMed ID: 16821785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 20-(S)-camptothecin analogues as DNA topoisomerase I inhibitors: a QSAR study.
    Hansch C; Verma RP
    ChemMedChem; 2007 Dec; 2(12):1807-13. PubMed ID: 17886246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of polarizability in QSAR.
    Verma RP; Kurup A; Hansch C
    Bioorg Med Chem; 2005 Jan; 13(1):237-55. PubMed ID: 15582468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR analysis of 1,3-diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives as selective COX-2 inhibitors.
    Silakari P; Shrivastava SD; Silakari G; Kohli DV; Rambabu G; Srivastava S; Shrivastava SK; Silakari O
    Eur J Med Chem; 2008 Jul; 43(7):1559-69. PubMed ID: 18023931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A density functional study of flavonoid compounds with anti-HIV activity.
    Lameira J; Alves CN; Moliner V; Silla E
    Eur J Med Chem; 2006 May; 41(5):616-23. PubMed ID: 16530886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
    Ottanà R; Carotti S; Maccari R; Landini I; Chiricosta G; Caciagli B; Vigorita MG; Mini E
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3930-3. PubMed ID: 15993594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
    Chen KX; Xie HY; Li ZG; Gao JR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-androgen-independent prostate cancer effects of ginsenoside metabolites in vitro: mechanism and possible structure-activity relationship investigation.
    Li W; Liu Y; Zhang JW; Ai CZ; Xiang N; Liu HX; Yang L
    Arch Pharm Res; 2009 Jan; 32(1):49-57. PubMed ID: 19183876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of the binding mode of biarylpropylsulfonamide allosteric AMPA receptor modulators based on docking, GRID molecular interaction fields and 3D-QSAR analysis.
    Harpsøe K; Liljefors T; Balle T
    J Mol Graph Model; 2008 Jan; 26(5):874-83. PubMed ID: 17644444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of novel acyclic versions of Neplanocin A.
    Wu Y; Hong JH
    Arch Pharm (Weinheim); 2005 Nov; 338(11):517-21. PubMed ID: 16281309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of electronic, lipophilic and membrane affinity effects on antiproliferative activity of 5-substituted-2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles against various human cancer cells.
    Matysiak J
    Eur J Med Chem; 2007 Jul; 42(7):940-7. PubMed ID: 17320247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.